Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (Industry)

(T 19) Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Return to Function Endpoint Analysis from MOMENTUM

    Presenting Author(s)

  • Richard B. Lipton, MD

    Edwin S. Lowe Professor and Vice Chair of Neurology; Director, Montefiore Headache Center
    Montefiore Medical Center and the Albert Einstein College of Medicine
    Bronx, NY, United States

    • Non-presenting Author(s)

  • GE

    Graham M.L. Eglit, PhD

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • CL

    Cherisse Loucks, PhD

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • AC

    Angad Chhabra, BS

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • TG

    Todd Grinnell, BS

    Axsome Therapeutics, Inc.
    New York, New York, United States

  • Chia-Chun Chiang, MD

    Associate Professor of Neurology
    Mayo Clinic
    Rochester, MN, United States